Jublia does not currently have a generic version available in the United States [1].
When might a generic Jublia become available?
The patent for Jublia, efinaconazole topical solution, is set to expire in 2029 [2]. This expiration date is crucial because it generally allows for the development and introduction of generic alternatives.
What is Jublia used for?
Jublia is a topical antifungal medication prescribed to treat onychomycosis, a fungal infection of the nails [1]. It works by inhibiting fungal cell wall synthesis [3].
Who makes Jublia?
Jublia is manufactured by Bausch Health Companies [1].
How does Jublia compare to other nail fungus treatments?
Jublia is a prescription topical treatment, which differentiates it from over-the-counter options. Its efficacy is typically evaluated through clinical trials that assess the percentage of patients achieving a complete cure and treatment success at specific time points after completing therapy [3]. Other treatments for nail fungus include oral antifungal medications and other topical formulations, each with different mechanisms of action, efficacy rates, and side effect profiles [4].
What are the potential side effects of Jublia?
Common side effects reported with Jublia include redness, itching, and irritation at the application site [1].